Similarly, the mTOR inhibitor rapamycin, previously reported to decrease EWS/FLI protein in Ewing sarcoma cell lines, induced the EWS/FLI off signature as assessed by our GE-HTS assay [27,28]. Here, FLII is linked to Ewing sarcoma.